| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |